Previously described ATRA-responsive genes characterised in this study as direct RXR α -RAR γ targets, or as part of the functional co-citation network.
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Supplementary Information
Supplementary Figure S1:
• ATRA-induced F9 cell differentiation validated by gene expression markers.
• RXR α localization by ChIP-seq assays in the context of well-known characterised RARE sites. • Genomic context of Global RXR α localization during F9 induced differentiation.
Supplementary Figure S2:
• Examples illustrating the temporal patterns of genome-wide chromatin-binding of RXR α and RAR γ established by ChIP-seq profiling and validated by ChIP-qPCR. Supplementary Figure S3 :
• RNA Polymerase II recruitment at transcriptionally active genes monitored by ChIPseq. • POLYPHEMUS: In silico method to normalize and compare the relative PolII enrichment for multiple genes at TSSs and gene bodies. Supplementary Figure S4 :
• Monitoring temporal recruitment of nuclear receptor co-activator components (RAC3; P300) at defined RXR α -RAR γ gene targets by ChIP-qPCR. • Temporal changes of mRNA levels for RXR α -RAR γ gene targets (Aqp3; Notch4; Ksr1; Nostrin).
Supplementary Figure S5:
• F9 cell differentiation induced by the RAR γ -specific ligand (BMS961) in comparison to ATRA treatment validated by cell morphology and differentiation markers. Supplementary Figure S6 :
• TF-target gene enrichment in DREM-predicted co-expression cohorts.
• Comparative temporal patterns of transcriptional regulation of indicated TFs in F9 cells in response to ATRA or RAR isotype-selective agonists. Supplementary Figure S7 :
• mRNA expression levels for Nostrin, Bmp2 and GAPDH in F9 transfected cells with siRNA constructs against Transcription factors. Supplementary Figure S8 :
• Gene Ontology terms enrichment associated to the different co-expression paths.
Supplementary Figure S9:
• Genes illustrated in the functional co-citation network depicted in the context of their transcriptional patterns over all studied time-points for ATRA, RAR γ -specific agonist (BMS961), RAR α -specific agonist (BMS753) and RAR β -specific agonist (BMS641). Supplementary File S1:
• Cytoscape file for ATRA-induced RXR α -RAR γ functional co-citation network.
Supplementary File S2:
• Cytoscape file for ATRA-induced RXR α -RAR γ functional co-citation network displaying temporal transcriptomics information per node associated to ATRA and RAR-specific agonists treatment. Supplementary File S3:
• RXR α -RAR γ functional co-citation network illustrating the temporal transcriptomics information per node associated to ATRA treatment (pps format) Supplementary File S4:
• RXR α -RAR γ functional co-citation network illustrating the temporal transcriptomics information per node associated to RAR γ -specific agonist (BMS961) treatment (pps format).
Supplementary File S5:
• RXR α -RAR γ functional co-citation network illustrating the temporal transcriptomics information per node associated to RAR α -specific agonist (BMS753) treatment (pps format).
Supplementary File S6:
• RXR α -RAR γ functional co-citation network illustrating the temporal transcriptomics information per node associated to RAR β -specific agonist (BMS641) treatment (pps format). Supplementary Table I: The top-100 ranked nodes based on topology scoring methods (MNC and DMNC) are displayed together with their first level neighbours (rainbow gradient and white nodes respectively). Nodes responding to ATRA and BMS961 treatment are illustrated with red borders. In addition, each co-expression path composing the ATRA-induced dynamic regulatory map ( Figure 5 ) is delimited by the colouring of the edges (Notice that the colours correlate with that of the co-expression paths) and their thickness is proportional to the number of co-citations. Finally, some functional annotations associated to certain nodes are also displayed (Cell cycle regulation; Proliferation; Apoptosis; Differentiation; Self-renewal pluripotency).
Supplementary File S2:
Cytoscape file for ATRA-induced RXR α -RAR γ functional co-citation network displaying temporal transcriptomics information per node associated to ATRA and RAR-specific agonists treatment. In addition to the attributes described for Supplementary File S1, we have included transcriptomics information as a way to follow nodes temporal expression for different ligand treatments. In this case, node's colour ranges red-white-green gradient based on their differential expression relative to the 0h control sample. In order to display different time-points/ligand transcriptional information, users may go through "Vizmapper" and select (click over the blue displayed attribute) the node colour attribute (e.g. 2h_ATRA) of interest. Notice that under this representation, the top-100 ranked nodes loose their rainbow gradient colouring but they keep their size ranking representation (bigger node correspond to the nodes in the top list of the ranking). Figure S1 . (A) F9 cell differentiation induced by ATRA treatment has been followed by the early gene induction of genes like Hoxa1 and Rarβ as well as by late expression markers like Collagen type IV. The gene induction levels were normalized relative to constitutively expressed 36B4 and expressed relative to the 0h control sample. (B) Schematic representation of previously characterized RARE elements in the Cyp26a1 promoter region. (C) ChIP-seq profile for RNA polymerase II as a control of transcriptional activity; the RXRα recruitment to R2 and R1 after 24h of ATRA treatment is illustrated. In addition, ChIP-seq profiles for RXRα localization in rxrα-/-F9 strain and for an input control are depicted. Note that in addition to R1 and R2, a RXRα binding event~1.5kb downstream is observed (R3). (D) RXRα binding during ATRA-induced F9 cell differentiation is preferentially found at intergenic regions. (E) The intergenic binding events were preferentially located far away from coding regions. Only 30 percent of all identified sites located in intergenic regions were found in a 10kb gene distance for all studied time-points (left panel). The intragenic RXRα binding is also preferentially found at intronic regions (right panel). Please note that the assignment of response element activity to an occupied binding site is at present merely correlative, based on proximity of the bound factor to the regulated gene. Supplementary Figure S2 . Examples illustrating the diversity in the temporal recruitment of RXR and RAR as revealed by ChIP-seq profiling and validated by ChIP-qPCR. Fold occupancies have been calculated relative to a cold region located at 18kb downstream of the Hoxb1 gene. Supplementary Figure S3 . (A) RNA PolII ChIP-seq profiling facilitates the study of polymerase recruitment to TSS regions; active gene transcription is revealed by its enrichment over the gene body. With the aim of evaluating the occurrence of these events in the context of the ATRA-induced F9 cell differentiation, we have developed POLYPHEMUS, which normalizes the PolII ChIP-seq profiles; standardizes genes length and provides this information as a ratio between the normalized PolII enrichment levels at a given time-point relative to the 0h control. As illustrated in the right panel, this PolII data processing permits the visualization of PolII enrichment along the entire genes; in addition it allows to compare the PolII activity over different genes. This particular example displays the relative PolII enrichment at 2h of ATRA treatment. (B) RNA PolII enrichment for genes shown in (A) are represented in absence or presence of ATRA treatment (green profiles) and are correlated with RXR -RAR binding in proximity. Red and blue profiles corresponds to metaprofiles for RXR and RAR respectively. In addition, a metaprofile for RNA PolII has been defined as the combination of all uniquely aligned reads associated to the ATRA treated samples. 
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Supplementary Figure S6. (A)
Differential mRNA gene expression time-series data from ATRA-induced F9 cell differentiation were classified by DREM in six different classes based on their co-expression characteristics (compare Figure 5 ). DREM hypothesizes that the different classes are driven by gene-expression bifurcation events (green nodes) which are the consequence of a direct influence of certain TFs. Following this hypothesis, DREM integrates TF-gene target information into the dynamic co-expression path classification by estimating an over-enrichment score per TF (black-yellow gradient heat map) associated to the different gene co-expression classes (paths). In this study we have included RXRα-RARγ ChIP-seq identified direct targets and TF-target gene annotations obtained from the NCBI database and/or predicted by MatInspector (Genomatix software suite) as part of the potential TF-gene regulators. Note that RXRα-RARγ present important overenrichment scores when associated to classes (i) and (ii). In a similar manner, TFs like Sox2 and Egr1 are associated to class (vi).
(B)
The temporal changes of the mRNA expression levels of the TFs displayed in (A) illustrated for different ligand treatment conditions: ATRA, RARγ-specific BMS961, RARα-specific BMS753 and RARβ−specific BMS641. Hoxb2, Hoxb5, Foxa2, Gata4; shown to be upregulated during ATRA-induced F9 cell differentiation and predicted to have a direct influence in gene-expression bifurcation events (DREM) were partially knockdown by siRNA transfection. In Addition, Foxa1, a TF specifically induced during ATRA or BMS961 treatment (but not during BMS753 or BMS641 treatment) has been also included in this assay. The specificity of the transfection assay has been evaluated by using siRNA oligomers directed against GFP coding region. The corresponding gene induction levels either under Ethanol treatment (48h) or under specific siRNA transfection followed by ATRA treatment levels either under Ethanol treatment (48h) or under specific siRNA transfection followed by ATRA treatment were expressed relative to the control levels. (B) In support to figure 5E , the effect of the TFs-silencing on genes like Nostrin (a newly characterized RXRα-RARγ direct target), Bmp2 (Bone morphogenetic protein 2, a previously characterized RA-induced gene) as well as the constitutively expressed GAPDH gene were evaluated. In contrast to the decrease observed for the mRNA levels of basement membrane components ( figure 5E ), the effect on these genes appeared to be less important. regionalization pattern specification process embryo development tube development cell development cell differentiation (1.9x10 -4 / 3.5x10 -5 ) cellular developmental process regulation of developmental process anterior/posterior pattern formation positive regulation of macromolecule biosynthetic process positive regulation of macromolecule metabolic process tissue morphogenesis response to external stimulus regulation of cell proliferation positive regulation of cellular metabolic process regulation of cell differentiation DNA binding positive regulation of biosynthetic process positive regulation of cellular biosynthetic process positive regulation of metabolic process positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process positive regulation of nitrogen compound metabolic process tube morphogenesis response to chemical stimulus positive regulation of cellular process regulation of multicellular organismal process signal transducer activity receptor activity cell migration cell motility localization of cell regulation of biological process regulation of cellular process muscle structure development positive regulation of cell differentiation (1.1x10 -3 ) positive regulation of developmental process morphogenesis of an epithelium response to extracellular stimulus response to nutrient response to nutrient levels regulation of macromolecule metabolic process regulation of primary metabolic process receptor binding central nervous system development negative regulation of cell proliferation embryonic organ development sensory organ development regulation of biosynthetic process regulation of cellular biosynthetic process gene expression cellular macromolecule biosynthetic process nervous system development negative regulation of cellular process negative regulation of biological process regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process regulation of nitrogen compound metabolic process transcription regulation of transcription regulation of cellular metabolic process regulation of macromolecule biosynthetic process regulation of cellular macromolecule biosynthetic process lipid binding system process skeletal system morphogenesis regulation of hormone levels RNA metabolic process negative regulation of cellular metabolic process negative regulation of transcription from RNA polymerase II promoter negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process negative regulation of transcription, DNA-dependent negative regulation of RNA metabolic process negative regulation of cellular macromolecule biosynthetic process response to vitamin A (1.4x10 -4 ) regulation of myeloid leukocyte differentiation hormone metabolic process regulation of myeloid cell differentiation regulation of gene expression regulation of metabolic process embryonic organ morphogenesis negative regulation of metabolic process negative regulation of macromolecule metabolic process transcription, DNA-dependent RNA biosynthetic process regulation of transcription, DNA-dependent regulation of RNA metabolic process immune system development hemopoiesis hemopoietic or lymphoid organ development leukocyte differentiation striated muscle tissue development response to vitamin myeloid cell differentiation epithelial cell differentiation muscle tissue development myeloid leukocyte differentiation positive regulation of transcription from RNA polymerase II promoter regulation of transcription from RNA polymerase II promoter transcription from RNA polymerase II promoter positive regulation of transcription, DNA-dependent positive regulation of RNA metabolic process epithelium development positive regulation of transcription (4.6x10 -5 ) (i)(ii)(iii)(iv)(v)(vi) anatomical structure morphogenesis organ development tissue development system development multicellular organismal development anatomical structure development organ morphogenesis positive regulation of gene expression sequence-specific DNA binding regulation of immune system process embryonic morphogenesis (1.91x10 -5 ) positive regulation of biological process regulation of multicellular organismal development amine metabolic process cellular amine metabolic process cell cycle (1x10 -2 ) protein oligomerization response to DNA damage stimulus steroid metabolic process (2.3x10 -4 ) sterol metabolic process (2.4x10-4) cholesterol biosynthetic process (6.21x10 -4 ) cholesterol metabolic process(4.31x10 -4 ) sterol biosynthetic process(3.3x10 -4 ) RNA binding nucleoside-triphosphatase activity DNA repair steroid biosynthetic process RNA processing rRNA processing isoprenoid biosynthetic process rRNA metabolic process ribonucleoprotein complex biogenesis ncRNA processing ncRNA metabolic process ribosome biogenesis cellular component biogenesis at cellular level 1x10 -1 1x10 -4 GO enrichment p-value (i)(ii)(iii)(iv)(v)(vi) Figure S8 . Gene Ontology (GO) p-values for each identified co-expression path were computed by the Dynamic Regulatory Events Miner (DREM), then the GO terms associated to all classes were clustered using a Self Organization Tree Algorithm (SOTA: number of cycles=5; cell variability pvalue=0.01). 
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